TABLE OF CONTENTS
Volume 14, Issue 10 (October 2007)
Original Articles
IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer
H Wang, G Yang, T L Timme, T Fujita, K Naruishi, A Frolov, M K Brenner, D Kadmon and T C Thompson
Cancer Gene Ther 14: 819-827; advance online publication, July 13, 2007; doi:10.1038/sj.cgt.7701069
Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors
R S Rachakatla, F Marini, M L Weiss, M Tamura and D Troyer
Cancer Gene Ther 14: 828-835; advance online publication, June 29, 2007; doi:10.1038/sj.cgt.7701077
Targeted-simultaneous expression of Gas1 and p53 using a bicistronic adenoviral vector in gliomas
J A Benítez, L Arregui, P Vergara and J Segovia
Cancer Gene Ther 14: 836-846; advance online publication, June 29, 2007; doi:10.1038/sj.cgt.7701076
Expression of the chemokine receptor CCR6 in the Lewis lung carcinoma (LLC) cell line reduces its metastatic potential in vivo
A Sutherland, J-F Mirjolet, A Maho and M Parmentier
Cancer Gene Ther 14: 847-857; advance online publication, June 29, 2007; doi:10.1038/sj.cgt.7701074
Cellular and molecular events associated with the antitumor response induced by the cytosine deaminase/5-fluorocytosine suicide gene therapy system in a rat liver metastasis model
S Bertin, S Neves, A Gavelli, P Baqué, N Brossette, S Simões, M C Pedroso de Lima and V Pierrefite-Carle
Cancer Gene Ther 14: 858-866; advance online publication, June 22, 2007; doi:10.1038/sj.cgt.7701075
Short Communication
Reovirus decreases azoxymethane-induced aberrant crypt foci and colon cancer in a rodent model
T Alain, J F Wong, R Endersby, S J Urbanski, P W Lee, D A Muruve, R N Johnston, P A Forsyth and P L Beck
Cancer Gene Ther 14: 867-872; advance online publication, July 13, 2007; doi:10.1038/sj.cgt.7701068
